Mayer Arie
- SEC CIK
- 0001796583
Latest role at each company
- ORMP ORAMED PHARMACEUTICALS INC.Directoras of Jan 5, 2026
Trades
Every Form 4 that lists Mayer Arie as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| ORMPORAMED PHARMACEUTICALS INC. | Apr 4, 2023 | Apr 3 – Apr 4, 2023 | Mayer ArieDirector | PPurchaseCommon Stock | +8.81K | $2.2157 | +$19.52K | 26.81K | +48.9% | SEC |
| ORMPORAMED PHARMACEUTICALS INC. | May 10, 2022 | Nov 1, 2021 | Mayer ArieDirector | SSaleCommon Stock | −3K | $25.60 | −$76.8K | 0 | −100.0% | SEC |